ARX vs SPL

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

51MEDIUM

SPL

STARPHARMA FPO [SPL]

51MEDIUM

Score Breakdown

ARX SPL
Technical
29
60
Catalyst
53
61
Sentiment
50
50
Fundamental
78
72
Momentum
69
82
Risk Gate
47
50

Key Metrics

ARX Metric SPL
$201.1MMarket Cap$193.2M
60KAvg Volume (20d)1.7M
+0.1%Short Interest+0.1%
$0.80052-Week High$0.525
$0.35052-Week Low$0.082
-3.5%Daily Change+0.0%
$0.550Entry Price$0.460
-2.0%ROE-14.5%
-2.0%Profit Margin-22.2%

Active Signals

ARX Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Trading below both moving averages — the trend is working against this one
●Volume surging at 2.1x normal while price falls — heavy selling pressure
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (2.2x)
●Moderate revenue growth (+15%)

SPL Signals

●Stochastic is stretched into overbought — could need a breather
●Trading above both moving averages — the trend is your friend here
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (86 quarters)
●Moderate P/S ratio (13.3x)

Ask Scout AI to compare ARX and SPL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
ARX Full Analysis → SPL Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).